MedTrace Logo

Clinical Effectiveness and Safety of Intraoperative Methadone in Patients Undergoing Laparoscopic Hysterectomy

NCT03908060 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2022-11-02

No results posted yet for this study

Summary

The role of a single-dose of intraoperative methadone on postoperative pain and opioid consumption in patients undergoing hysterectomy remains scarcely explored. A prospective double-blind, randomised controlled trial investigating the effect of a single-dose of intraoperative methadone in patients scheduled for same day hysterectomy is therefore conducted.

Conditions

  • Postoperative Pain

Interventions

DRUG

Methadone

One intravenous administration of methadone (0.2 mg/kg ideal body weight)

DRUG

Morphine

One intravenous administration of morphine (0.2 mg/kg ideal body weight)

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Kristian Friesgaard, MD, PhD · Department of Anaesthesiology and Intensive Care, Horsens Regional Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-06
Primary Completion
2022-07-08
Completion
2022-12-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03908060 on ClinicalTrials.gov